Type 2 Diabetes Drug Attorney in Austin, TX

SGLT2 Inhibitor Drugs

Lawsuits are now being prepared against the manufacturers of SGLT2 Inhibitor drugs, including INVOKANA, ONGLYZA and KOMBIGLYZE XR.  Other common names of these drugs include INVOKAMET, FARXIGA, XIGDUO XR, GLYXAMBI and JARDIANCE.  Manufacturers and marketers include some of the biggest names in pharmaceuticals, such as Johnson & Johnson, Janssen Pharmaceuticals Inc., AstraZeneca and Boehringer Ingelheim.  If you or a loved one have been prescribed any of these drugs and have suffered kidney failure, heart attack or diabetic ketoacidosis, please contact my office immediately.

Basis of the Lawsuits

The main focus of these suits is the failure of the manufacturers and marketers to warn physicians and patients of the increased risks of kidney failure, myocardial infarction (heart attacks), other cardiovascular issues and diabetic ketoacidosis.  If proper warnings had been given, patients could have been prescribed a substitute medication for their diabetes, or at the very least could have been closely monitored for potential signs of heart issues, renal impairment and high levels of ketones.

Common Symptoms

• Chest pains

• Abdominal pains

• Frequent urination

• Extreme thirst that lasts a day or more

• Decreased alertness or confusion (even hallucinations)

• Fatigue

 • Flushed face

• Headaches

• Nausea and vomiting

• Muscle stiffness and aches

Experience Counts

Because of the complexities of pharmaceutical litigation, having an experienced Type 2 Diabetes Drug lawyer on your side can make all the difference.  An attorney with the financial backing and experience to handle these cases from start to finish is an absolute must to get fully compensated for your loss.  Earl Straight has handled these cases for 28 years, has a proven track record and is available to answer any questions you may have about defective product claims.  Call 512-454-1331 for a free consultation.